Study shows low rate of late lumen loss with bioresorbable DESolve device

Bioresorbable drug-eluting scaffolds are emerging as the dominant device of the future for percutaneous coronary interventions

2013-05-22

(Press-News.org) 21 May 2013, Paris, France: The DESolve bioresorbable coronary scaffold system achieves good efficacy and safety with low rates of late lumen loss and major coronary adverse events at six months, show first results from the pivotal DESolve Nx trial reported at EuroPCR 2013 today. DESolve (Elixir Medical Corporation) is the first bioresorbable PLLA-based polymer scaffold that releases novolimus, a major metabolite of sirolimus. "The degradation time is about one year," explained the lead study author Alexandre Abizaid, Director of Interventional Cardiology at Institute Dante Pazzanese de Cardiologia, São Paulo, Brazil. He added, "One of the most attractive features, which we don't see with most bioresorbable scaffolds, is that this device shows significant increase in vessel scaffold and luminal area at six months." The DESolve Nx trial treated target lesions in 126 patients with single de novo coronary artery lesions with the DESolve device. Results showed the primary endpoint of in-stent late lumen loss was 0.21mm (+0.34) at six months. Major adverse cardiac events occurred in 3.25% of patients, including one cardiac death. Acute recoil occurred in 6.6% of patients at six months. Stents and vessels were assessed by IVUS in a subset of 40 patients. "There was a clearly significant increase in vessel area," Abizaid reported. Mean vessel area increased by 16.8% at six months (p END

ELSE PRESS RELEASES FROM THIS DATE:

Whirlpools on the nanoscale could multiply magnetic memory

2013-05-22

"We spent 15 percent of home energy on gadgets in 2009, and we're buying more gadgets all the time," says Peter Fischer of the U.S. Department of Energy's Lawrence Berkeley National Laboratory (Berkeley Lab). Fischer lets you know right away that while it's scientific curiosity that inspires his research at the Lab's Advanced Light Source (ALS), he intends it to help solve pressing problems. "What we're working on now could make these gadgets perform hundreds of times better and also be a hundred times more energy efficient," says Fischer, a staff scientist in the Materials ...

UCLA life scientists present new insights on climate change and species interactions

2013-05-22

UCLA life scientists provide important new details on how climate change will affect interactions between species in research published online May 21 in the Journal of Animal Ecology. This knowledge, they say, is critical to making accurate predictions and informing policymakers of how species are likely to be impacted by rising temperatures. "There is a growing recognition among biologists that climate change is affecting how species interact with one another, and that this is going to have very important consequences for the stability and functioning of ecosystems," ...

UCI chemists devise inexpensive, accurate way to detect prostate cancer

2013-05-22

Irvine, Calif., May 22, 2013 – Early screening for prostate cancer could become as easy for men as personal pregnancy testing is for women, thanks to UC Irvine research published today in the Journal of the American Chemical Society. After more than a decade of work, UC Irvine chemists have created a way to clearly identify clinically usable markers for prostate cancer in urine, meaning that the disease could be detected far sooner, with greater accuracy and at dramatically lower cost. The same technology could potentially be used for bladder and multiple myeloma cancers, ...

Study finds COPD is over-diagnosed among uninsured patients

2013-05-22

ATS 2013, PHILADELPHIA ─More than 40 percent of patients being treated for COPD at a federally funded clinic did not have the disease, researchers found after evaluating the patients with spirometry, the diagnostic "gold standard" for chronic obstructive pulmonary disease. "While there have been many studies of the under-diagnosis of COPD, there has not been a U.S.-based study that has quantified the problem of over-diagnosis," said Christian Ghattas, MD., MSc, a second-year medical resident at Saint Elizabeth Health Center in Youngstown, Ohio, who will present ...

Scientists uncover molecular roots of cocaine addiction in the brain

2013-05-22

Researchers at Johns Hopkins have unraveled the molecular foundations of cocaine's effects on the brain, and identified a compound that blocks cravings for the drug in cocaine-addicted mice. The compound, already proven safe for humans, is undergoing further animal testing in preparation for possible clinical trials in cocaine addicts, the researchers say. "It was remarkably serendipitous that when we learned which brain pathway cocaine acts on, we already knew of a compound, CGP3466B, that blocks that specific pathway," says Solomon Snyder, M.D., a professor of neuroscience ...

Addiction to unhealthy foods could help explain the global obesity epidemic

2013-05-22

Toronto, May 22 2013 - Research presented today shows that high-fructose corn syrup can cause behavioural reactions in rats similar to those produced by drugs of abuse such as cocaine. These results, presented by addiction expert Francesco Leri, Associate Professor of Neuroscience and Applied Cognitive Science at the University of Guelph, suggest food addiction could explain, at least partly, the current global obesity epidemic. These results were presented at the 2013 Canadian Neuroscience Meeting, the annual meeting of the Canadian Association for Neuroscience - Association ...

Addiction as a disorder of decision-making

2013-05-22

Toronto - May 22 2013: New research shows that craving drugs such as nicotine can be visualized in specific regions of the brain that are implicated in determining the value of actions, in planning actions and in motivation. Dr. Alain Dagher, from McGill University, suggests abnormal interactions between these decision-making brain regions could underlie addiction. These results were presented at the 2013 Canadian Neuroscience Meeting, the annual meeting of the Canadian Association for Neuroscience - Association Canadienne des Neurosciences (CAN-ACN). Neuroeconomics is ...

How healthy are you for your age?

2013-05-22

VIDEO: The video as it appears on JoVE.com. Click here for more information. On May 22, JoVE will publish details of a technique to measure the health of human genetic material in relation to a patient’s age. The method is demonstrated by the laboratory of Dr. Gil Atzmon at New York’s Albert Einstein College of Medicine. Dr. Atzmon hopes that the dissemination of this technique will lead to the development of a “genetic thermometer” to assess a patient’s health in relation to ...

Costs to treat stroke in America may double by 2030

2013-05-22

Costs to treat stroke are projected to more than double and the number of people having strokes may increase 20 percent by 2030, according to the American Heart Association/American Stroke Association. In a statement published in Stroke, an American Heart Association journal, the association cites the aging U.S. population as the main reason for the increases and predicts that by 2030: Almost 4 percent of U.S. adults — nearly one in 25 — will have a stroke. This translates into an additional 3.4 million people with stroke in 2030. Costs to treat stroke may increase ...

Taming suspect gene reverses schizophrenia-like abnormalities in mice

2013-05-22

Scientists have reversed behavioral and brain abnormalities in adult mice that resemble some features of schizophrenia by restoring normal expression to a suspect gene that is over-expressed in humans with the illness. Targeting expression of the gene Neuregulin1, which makes a protein important for brain development, may hold promise for treating at least some patients with the brain disorder, say researchers funded by the National Institutes of Health. Like patients with schizophrenia, adult mice biogenetically-engineered to have higher Neuregulin 1 levels showed reduced ...